# SEntine Lymph Node in earLY Ovarian Cancer (SELLY)

> **NCT03563781** · NA · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 176 (actual)

## Conditions studied

- Sentinel Lymph Node
- Ovarian Cancer Stage I

## Interventions

- **PROCEDURE:** Sentinel node detection

## Key facts

- **NCT ID:** NCT03563781
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-11
- **Primary completion:** 2022-07-29
- **Final completion:** 2023-05-05
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563781, "SEntine Lymph Node in earLY Ovarian Cancer (SELLY)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03563781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*